{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:17:07Z","timestamp":1789611427393,"version":"build-2803163510"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T00:00:00Z","timestamp":1666915200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRB ILP POR 2019-005"],"award-info":[{"award-number":["HRB ILP POR 2019-005"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRB ILP POR 2019-005"],"award-info":[{"award-number":["HRB ILP POR 2019-005"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRB\/HRA\/PHR\/2015-1293"],"award-info":[{"award-number":["HRB\/HRA\/PHR\/2015-1293"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRB\/HRA\/PHR\/2015-1293"],"award-info":[{"award-number":["HRB\/HRA\/PHR\/2015-1293"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRB ILP POR 2019-005"],"award-info":[{"award-number":["HRB ILP POR 2019-005"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010414","name":"Health Research Board","doi-asserted-by":"publisher","award":["HRB\/HRA\/PHR\/2015-1293"],"award-info":[{"award-number":["HRB\/HRA\/PHR\/2015-1293"]}],"id":[{"id":"10.13039\/100010414","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["16\/RC\/3948"],"award-info":[{"award-number":["16\/RC\/3948"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001602","name":"Science Foundation Ireland","doi-asserted-by":"publisher","award":["16\/RC\/3948"],"award-info":[{"award-number":["16\/RC\/3948"]}],"id":[{"id":"10.13039\/501100001602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"Department of Health | National Health and Medical Research Council","doi-asserted-by":"publisher","award":["566529"],"award-info":[{"award-number":["566529"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004440","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["220438Z\/20\/Z"],"award-info":[{"award-number":["220438Z\/20\/Z"]}],"id":[{"id":"10.13039\/100004440","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Transl Psychiatry"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>Preliminary evidence indicates beneficial effects of omega-3 polyunsaturated fatty acids (PUFAs) in early psychosis. The present study investigates the molecular mechanism of omega-3 PUFA-associated therapeutic effects in clinical high-risk (CHR) participants. Plasma samples of 126 CHR psychosis participants at baseline and 6-months follow-up were included. Plasma protein levels were quantified using mass spectrometry and erythrocyte omega-3 PUFA levels were quantified using gas chromatography. We examined the relationship between change in polyunsaturated PUFAs (between baseline and 6-month follow-up) and follow-up plasma proteins. Using mediation analysis, we investigated whether plasma proteins mediated the relationship between change in omega-3 PUFAs and clinical outcomes. A 6-months change in omega-3 PUFAs was associated with 24 plasma proteins at follow-up. Pathway analysis revealed the complement and coagulation pathway as the main biological pathway to be associated with change in omega-3 PUFAs. Moreover, complement and coagulation pathway proteins significantly mediated the relationship between change in omega-3 PUFAs and clinical outcome at follow-up. The inflammatory protein complement C5 and protein S100A9 negatively mediated the relationship between change in omega-3 PUFAs and positive symptom severity, while C5 positively mediated the relationship between change in omega-3 and functional outcome. The relationship between change in omega-3 PUFAs and cognition was positively mediated through coagulation factor V and complement protein C1QB. Our findings provide evidence for a longitudinal association of omega-3 PUFAs with complement and coagulation protein changes in the blood. Further, the results suggest that an increase in omega-3 PUFAs decreases symptom severity and improves cognition in the CHR state through modulating effects of complement and coagulation proteins.<\/jats:p>","DOI":"10.1038\/s41398-022-02217-0","type":"journal-article","created":{"date-parts":[[2022,10,28]],"date-time":"2022-10-28T17:06:30Z","timestamp":1666976790000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":12,"title":["Evidence that complement and coagulation proteins are mediating the clinical response to omega-3 fatty acids: A mass spectrometry-based investigation in subjects at clinical high-risk for psychosis"],"prefix":"10.1038","volume":"12","author":[{"given":"Subash Raj","family":"Susai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colm","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7931-9636","authenticated-orcid":false,"given":"David","family":"Mongan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0105-2702","authenticated-orcid":false,"given":"Meike","family":"Heurich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7046-0630","authenticated-orcid":false,"given":"Jonah F.","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7189-9496","authenticated-orcid":false,"given":"Gerard","family":"Cagney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran","family":"Wynne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie","family":"Markulev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam R.","family":"Sch\u00e4fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5255-0838","authenticated-orcid":false,"given":"Maximus","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilufar","family":"Mossaheb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Schl\u00f6gelhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Smesny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8832-9895","authenticated-orcid":false,"given":"Ian B.","family":"Hickie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2030-141X","authenticated-orcid":false,"given":"Gregor E.","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric Y. H.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieuwe","family":"de Haan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorien H.","family":"Nieman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merete","family":"Nordentoft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6361-8789","authenticated-orcid":false,"given":"Anita","family":"Riecher-R\u00f6ssler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapna","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebekah","family":"Street","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0401-9791","authenticated-orcid":false,"given":"Alison Ruth","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barnaby","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick D.","family":"McGorry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6299-2952","authenticated-orcid":false,"given":"Melanie","family":"F\u00f6cking","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G. Paul","family":"Amminger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,10,28]]},"reference":[{"key":"2217_CR1","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1186\/s12944-020-01337-0","volume":"19","author":"MC Hsu","year":"2020","unstructured":"Hsu MC, Huang YS, Ouyang WC. Beneficial effects of omega-3 fatty acid supplementation in schizophrenia: Possible mechanisms. Lipids Health Dis. 2020;19:159.","journal-title":"Lipids Health Dis"},{"key":"2217_CR2","doi-asserted-by":"publisher","first-page":"52","DOI":"10.3389\/fnagi.2015.00052","volume":"7","author":"SC Dyall","year":"2015","unstructured":"Dyall SC. Long-chain omega-3 fatty acids and the brain: A review of the independent and shared effects of EPA, DPA, and DHA. Front Aging Neurosci. 2015;7:52.","journal-title":"Front Aging Neurosci"},{"key":"2217_CR3","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1097\/MCO.0000000000000141","volume":"18","author":"I Denis","year":"2015","unstructured":"Denis I, Potier B, Heberden C, Vancassel S. Omega-3 polyunsaturated fatty acids and brain aging. Curr Opin Clin Nutr Metab Care. 2015;18:139\u201346.","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"2217_CR4","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1186\/1476-511X-8-33","volume":"8","author":"BM Anderson","year":"2009","unstructured":"Anderson BM, Ma DW. Are all n-3 polyunsaturated fatty acids created equal? Lipids Health Dis. 2009;8:33.","journal-title":"Lipids Health Dis"},{"key":"2217_CR5","doi-asserted-by":"publisher","first-page":"614s","DOI":"10.3945\/jn.111.149633","volume":"142","author":"D Mozaffarian","year":"2012","unstructured":"Mozaffarian D, Wu JH. (n-3) fatty acids and cardiovascular health: Are effects of EPA and DHA shared or complementary? J Nutr. 2012;142:614s\u2013625s.","journal-title":"J Nutr"},{"key":"2217_CR6","doi-asserted-by":"crossref","unstructured":"Pusceddu MM, Kelly P, Stanton C, Cryan JF, Dinan TG. N-3 Polyunsaturated fatty acids through the lifespan: Implication for psychopathology. Int J Neuropsychopharmacol. 2016;19:pyw078.","DOI":"10.1093\/ijnp\/pyw078"},{"key":"2217_CR7","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1051\/rnd:2005046","volume":"45","author":"W Stillwell","year":"2005","unstructured":"Stillwell W, Shaikh SR, Zerouga M, Siddiqui R, Wassall SR. Docosahexaenoic acid affects cell signaling by altering lipid rafts. Reprod Nutr Dev. 2005;45:559\u201379.","journal-title":"Reprod Nutr Dev"},{"key":"2217_CR8","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.chemphyslip.2008.02.010","volume":"153","author":"SR Wassall","year":"2008","unstructured":"Wassall SR, Stillwell W. Docosahexaenoic acid domains: the ultimate non-raft membrane domain. Chem Phys Lipids. 2008;153:57\u201363.","journal-title":"Chem Phys Lipids"},{"key":"2217_CR9","doi-asserted-by":"publisher","first-page":"1260","DOI":"10.1016\/j.bbalip.2010.08.002","volume":"1801","author":"G Bannenberg","year":"2010","unstructured":"Bannenberg G, Serhan CN. Specialized pro-resolving lipid mediators in the inflammatory response: An update. Biochim Biophys Acta. 2010;1801:1260\u201373.","journal-title":"Biochim Biophys Acta"},{"key":"2217_CR10","doi-asserted-by":"publisher","first-page":"e29662","DOI":"10.1371\/journal.pone.0029662","volume":"6","author":"MK Gregory","year":"2011","unstructured":"Gregory MK, Gibson RA, Cook-Johnson RJ, Cleland LG, James MJ. Elongase reactions as control points in long-chain polyunsaturated fatty acid synthesis. PLoS One. 2011;6:e29662.","journal-title":"PLoS One"},{"key":"2217_CR11","doi-asserted-by":"publisher","first-page":"433","DOI":"10.1038\/nchembio.367","volume":"6","author":"AL Groeger","year":"2010","unstructured":"Groeger AL, Cipollina C, Cole MP, Woodcock SR, Bonacci G, Rudolph TK, et al. Cyclooxygenase-2 generates anti-inflammatory mediators from omega-3 fatty acids. Nat Chem Biol. 2010;6:433\u201341.","journal-title":"Nat Chem Biol"},{"key":"2217_CR12","doi-asserted-by":"publisher","first-page":"e94836","DOI":"10.1371\/journal.pone.0094836","volume":"9","author":"C Cipollina","year":"2014","unstructured":"Cipollina C, Salvatore SR, Muldoon MF, Freeman BA, Schopfer FJ. Generation and dietary modulation of anti-inflammatory electrophilic omega-3 fatty acid derivatives. PLoS One. 2014;9:e94836.","journal-title":"PLoS One"},{"key":"2217_CR13","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.bbi.2016.07.145","volume":"59","author":"RC Robertson","year":"2017","unstructured":"Robertson RC, Seira Oriach C, Murphy K, Moloney GM, Cryan JF, Dinan TG, et al. Omega-3 polyunsaturated fatty acids critically regulate behaviour and gut microbiota development in adolescence and adulthood. Brain, Behav, Immun. 2017;59:21\u201337.","journal-title":"Brain, Behav, Immun"},{"key":"2217_CR14","first-page":"E272","volume":"65","author":"Q Leyrolle","year":"2017","unstructured":"Leyrolle Q, Madore C, Joffre C, Gressens P, Lay\u00e9 S, Nadjar A. Early-life PUFAs modulate shaping of neuronal circuits by microglia. GLIA. 2017;65:E272.","journal-title":"GLIA"},{"key":"2217_CR15","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-020-19861-z","volume":"11","author":"C Madore","year":"2020","unstructured":"Madore C, Leyrolle Q, Morel L, Rossitto M, Greenhalgh AD, Delpech JC, et al. Essential omega-3 fatty acids tune microglial phagocytosis of synaptic elements in the mouse developing brain. Nat Commun. 2020;11:6133.","journal-title":"Nat Commun"},{"key":"2217_CR16","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/bs.ai.2017.06.004","volume":"135","author":"J Presumey","year":"2017","unstructured":"Presumey J, Bialas AR, Carroll MC. Complement system in neural synapse elimination in development and disease. Adv Immunol. 2017;135:53\u201379.","journal-title":"Adv Immunol"},{"key":"2217_CR17","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/j.jpsychires.2015.11.013","volume":"73","author":"T Pawelczyk","year":"2016","unstructured":"Pawelczyk T, Grancow-Grabka M, Kotlicka-Antczak M, Trafalska E, Pawelczyk A. A randomized controlled study of the efficacy of six-month supplementation with concentrated fish oil rich in omega-3 polyunsaturated fatty acids in first episode schizophrenia. J Psychiatr Res. 2016;73:34\u201344.","journal-title":"J Psychiatr Res"},{"key":"2217_CR18","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1016\/j.jpsychires.2012.10.005","volume":"47","author":"S Dipasquale","year":"2013","unstructured":"Dipasquale S, Pariante CM, Dazzan P, Aguglia E, McGuire P, Mondelli V. The dietary pattern of patients with schizophrenia: A systematic review. J Psychiatr Res. 2013;47:197\u2013207.","journal-title":"J Psychiatr Res"},{"key":"2217_CR19","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1016\/j.schres.2018.03.016","volume":"199","author":"AS Jakobsen","year":"2018","unstructured":"Jakobsen AS, Speyer H, N\u00f8rgaard HCB, Karlsen M, Hjorth\u00f8j C, Krogh J, et al. Dietary patterns and physical activity in people with schizophrenia and increased waist circumference. Schizophrenia Res. 2018;199:109\u201315.","journal-title":"Schizophrenia Res"},{"key":"2217_CR20","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.biopsych.2011.02.011","volume":"70","author":"H Bentsen","year":"2011","unstructured":"Bentsen H, Solberg DK, Refsum H, Gran JM, B\u00f8hmer T, Torjesen PA, et al. Bimodal distribution of polyunsaturated fatty acids in schizophrenia suggests two endophenotypes of the disorder. Biol Psychiatry. 2011;70:97\u2013105.","journal-title":"Biol Psychiatry"},{"key":"2217_CR21","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1016\/j.neuroimage.2010.05.009","volume":"52","author":"S Smesny","year":"2010","unstructured":"Smesny S, Milleit B, Nenadic I, Preul C, Kinder D, Lasch J, et al. Phospholipase A2 activity is associated with structural brain changes in schizophrenia. Neuroimage. 2010;52:1314\u201327.","journal-title":"Neuroimage"},{"key":"2217_CR22","first-page":"45","volume":"28","author":"M \u0160aki\u0107","year":"2016","unstructured":"\u0160aki\u0107 M, Karlovi\u0107 D, Vidrih B, Peitl V, Crnkovi\u0107 D, Vrki\u0107 N. Increased calcium-independent lipoprotein phospholipase A2 but not protein S100 in patients with schizophrenia. Psychiatr Danubina. 2016;28:45\u201350.","journal-title":"Psychiatr Danubina"},{"key":"2217_CR23","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1007\/s12017-009-8092-z","volume":"12","author":"GY Sun","year":"2010","unstructured":"Sun GY, Shelat PB, Jensen MB, He Y, Sun AY, Simonyi A. Phospholipases A2 and inflammatory responses in the central nervous system. Neuromolecular Med. 2010;12:133\u201348.","journal-title":"Neuromolecular Med"},{"key":"2217_CR24","doi-asserted-by":"publisher","first-page":"801","DOI":"10.1016\/j.biopsych.2007.09.024","volume":"63","author":"S Potvin","year":"2008","unstructured":"Potvin S, Stip E, Sepehry AA, Gendron A, Bah R, Kouassi E. Inflammatory cytokine alterations in schizophrenia: A systematic quantitative review. Biol Psychiatry. 2008;63:801\u20138.","journal-title":"Biol Psychiatry"},{"key":"2217_CR25","doi-asserted-by":"publisher","first-page":"739","DOI":"10.1016\/j.pnpbp.2004.05.009","volume":"28","author":"CU Pae","year":"2004","unstructured":"Pae CU, Yu HS, Lee KU, Kim JJ, Lee CU, Lee SJ, et al. BanI polymorphism of the cytosolic phospholipase A2 gene may confer susceptibility to the development of schizophrenia. Prog Neuro-Psychopharmacol Biol Psychiatry. 2004;28:739\u201341.","journal-title":"Prog Neuro-Psychopharmacol Biol Psychiatry"},{"key":"2217_CR26","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1007\/s00406-007-0736-0","volume":"257","author":"NR Barbosa","year":"2007","unstructured":"Barbosa NR, Junqueira RM, Vallada HP, Gattaz WF. Association between BanI genotype and increased phospholipase A2 activity in schizophrenia. Eur Arch Psychiatry Clin Neurosci. 2007;257:340\u20133.","journal-title":"Eur Arch Psychiatry Clin Neurosci"},{"key":"2217_CR27","doi-asserted-by":"publisher","first-page":"e0159584","DOI":"10.1371\/journal.pone.0159584","volume":"11","author":"G Yang","year":"2016","unstructured":"Yang G, Xu H, Zhang H, Yu Q, Wu Y, Shi J, et al. Association between PLA2G12A polymorphisms and schizophrenia in a Han Chinese population from Northeast China. PLoS One. 2016;11:e0159584.","journal-title":"PLoS One"},{"key":"2217_CR28","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1016\/S0920-9964(97)00151-5","volume":"30","author":"DF Horrobin","year":"1998","unstructured":"Horrobin DF. The membrane phospholipid hypothesis as a biochemical basis for the neurodevelopmental concept of schizophrenia. Schizophrenia Res. 1998;30:193\u2013208.","journal-title":"Schizophrenia Res"},{"key":"2217_CR29","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S0920-9964(99)00095-X","volume":"42","author":"JK Yao","year":"2000","unstructured":"Yao JK, Leonard S, Reddy RD. Membrane phospholipid abnormalities in postmortem brains from schizophrenic patients. Schizophrenia Res. 2000;42:7\u201317.","journal-title":"Schizophrenia Res"},{"key":"2217_CR30","doi-asserted-by":"publisher","first-page":"510","DOI":"10.1016\/S0006-3223(00)00986-0","volume":"49","author":"J Assies","year":"2001","unstructured":"Assies J, Lieverse R, Vreken P, Wanders RJA, Dingemans PMJA, Linszen DH. Significantly reduced docosahexaenoic and docosapentaenoic acid concentrations in erythrocyte membranes from schizophrenic patients compared with a carefully matched control group. Biol Psychiatry. 2001;49:510\u201322.","journal-title":"Biol Psychiatry"},{"key":"2217_CR31","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/S0920-9964(01)00334-6","volume":"58","author":"MM Khan","year":"2002","unstructured":"Khan MM, Evans DR, Gunna V, Scheffer RE, Parikh VV, Mahadik SP. Reduced erythrocyte membrane essential fatty acids and increased lipid peroxides in schizophrenia at the never-medicated first-episode of psychosis and after years of treatment with antipsychotics. Schizophrenia Res. 2002;58:1\u201310.","journal-title":"Schizophrenia Res"},{"key":"2217_CR32","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1016\/S0920-9964(02)00284-0","volume":"62","author":"M Arvindakshan","year":"2003","unstructured":"Arvindakshan M, Ghate M, Ranjekar PK, Evans DR, Mahadik SP. Supplementation with a combination of \u03c9-3 fatty acids and antioxidants (vitamins E and C) improves the outcome of schizophrenia. Schizophrenia Res. 2003;62:195\u2013204.","journal-title":"Schizophrenia Res"},{"key":"2217_CR33","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1080\/15622970410029917","volume":"5","author":"M Peet","year":"2004","unstructured":"Peet M, Shah S, Selvam K, Ramchand CN. Polyunsaturated fatty acid levels in red cell membranes of unmedicated schizophrenic patients. World J Biol Psychiatry. 2004;5:92\u201399.","journal-title":"World J Biol Psychiatry"},{"key":"2217_CR34","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1093\/oxfordjournals.schbul.a007140","volume":"30","author":"RD Reddy","year":"2004","unstructured":"Reddy RD, Keshavan MS, Yao JK. Reduced red blood cell membrane essential polyunsaturated fatty acids in first episode schizophrenia at neuroleptic-naive baseline. Schizophrenia Bull. 2004;30:901\u201311.","journal-title":"Schizophrenia Bull"},{"key":"2217_CR35","doi-asserted-by":"publisher","first-page":"47","DOI":"10.1016\/j.psychres.2009.01.013","volume":"175","author":"A Kale","year":"2010","unstructured":"Kale A, Naphade N, Sapkale S, Kamaraju M, Pillai A, Joshi S, et al. Reduced folic acid, vitamin B12 and docosahexaenoic acid and increased homocysteine and cortisol in never-medicated schizophrenia patients: implications for altered one-carbon metabolism. Psychiatry Res. 2010;175:47\u201353.","journal-title":"Psychiatry Res"},{"key":"2217_CR36","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.schres.2012.08.014","volume":"141","author":"WJM Van der Kemp","year":"2012","unstructured":"Van der Kemp WJM, Klomp DWJ, Kahn RS, Luijten PR, Pol HEH. A meta-analysis of the polyunsaturated fatty acid composition of erythrocyte membranes in schizophrenia. Schizophrenia Res. 2012;141:153\u201361.","journal-title":"Schizophrenia Res"},{"key":"2217_CR37","doi-asserted-by":"publisher","first-page":"e68717","DOI":"10.1371\/journal.pone.0068717","volume":"8","author":"J McEvoy","year":"2013","unstructured":"McEvoy J, Baillie RA, Zhu H, Buckley P, Keshavan MS, Nasrallah HA, et al. Lipidomics reveals early metabolic changes in subjects with schizophrenia: effects of atypical antipsychotics. PLoS One. 2013;8:e68717.","journal-title":"PLoS One"},{"key":"2217_CR38","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.plefa.2012.03.011","volume":"88","author":"RK McNamara","year":"2013","unstructured":"McNamara RK. Deciphering the role of docosahexaenoic acid in brain maturation and pathology with magnetic resonance imaging. Prostaglandins, Leukotrienes Essent Fat Acids. 2013;88:33\u201342.","journal-title":"Prostaglandins, Leukotrienes Essent Fat Acids"},{"key":"2217_CR39","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1016\/j.psychres.2015.04.036","volume":"228","author":"SM Rice","year":"2015","unstructured":"Rice SM, Schafer MR, Klier C, Mossaheb N, Vijayakumar N, Amminger GP. Erythrocyte polyunsaturated fatty acid levels in young people at ultra-high risk for psychotic disorder and healthy adolescent controls. Psychiatry Res. 2015;228:174\u20136.","journal-title":"Psychiatry Res"},{"key":"2217_CR40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.psychres.2012.09.041","volume":"207","author":"WP Hoen","year":"2013","unstructured":"Hoen WP, Lijmer JG, Duran M, Wanders RJA, van Beveren NJM, de Haan L. Red blood cell polyunsaturated fatty acids measured in red blood cells and schizophrenia: a meta-analysis. Psychiatry Res. 2013;207:1\u201312.","journal-title":"Psychiatry Res"},{"key":"2217_CR41","doi-asserted-by":"publisher","first-page":"146","DOI":"10.1001\/archgenpsychiatry.2009.192","volume":"67","author":"GP Amminger","year":"2010","unstructured":"Amminger GP, Schafer MR, Papageorgiou K, Klier CM, Cotton SM, Harrigan SM, et al. Long-chain omega-3 fatty acids for indicated prevention of psychotic disorders: a randomized, placebo-controlled trial. Arch Gen Psychiatry. 2010;67:146\u201354.","journal-title":"Arch Gen Psychiatry"},{"key":"2217_CR42","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/eip.12260","volume":"11","author":"C Markulev","year":"2017","unstructured":"Markulev C, McGorry PD, Nelson B, Yuen HP, Schaefer M, Yung AR, et al. NEURAPRO\u2010E study protocol: A multicentre randomized controlled trial of omega\u20103 fatty acids and cognitive\u2010behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders. Early Intervention Psychiatry. 2017;11:418\u201328.","journal-title":"Early Intervention Psychiatry"},{"key":"2217_CR43","doi-asserted-by":"publisher","first-page":"19","DOI":"10.1001\/jamapsychiatry.2016.2902","volume":"74","author":"PD McGorry","year":"2017","unstructured":"McGorry PD, Nelson B, Markulev C, Yuen HP, Sch\u00e4fer MR, Mossaheb N, et al. Effect of \u03c9-3 polyunsaturated fatty acids in young people at ultrahigh risk for psychotic disorders: The NEURAPRO randomized clinical trial. JAMA Psychiatry. 2017;74:19\u201327.","journal-title":"JAMA Psychiatry"},{"key":"2217_CR44","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1038\/mp.2013.7","volume":"19","author":"S Smesny","year":"2014","unstructured":"Smesny S, Milleit B, Hipler UC, Milleit C, Schafer MR, Klier CM, et al. Omega-3 fatty acid supplementation changes intracellular phospholipase A2 activity and membrane fatty acid profiles in individuals at ultra-high risk for psychosis. Mol Psychiatry. 2014;19:317\u201324.","journal-title":"Mol Psychiatry"},{"key":"2217_CR45","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1038\/sj.mp.4001819","volume":"11","author":"MH Law","year":"2006","unstructured":"Law MH, Cotton RGH, Berger GE. The role of phospholipases A2 in schizophrenia. Mol Psychiatry. 2006;11:547\u201356.","journal-title":"Mol Psychiatry"},{"key":"2217_CR46","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.schres.2017.01.026","volume":"188","author":"S Smesny","year":"2017","unstructured":"Smesny S, Milleit B, Schaefer MR, Hesse J, Schlogelhofer M, Langbein K, et al. Effects of omega-3 PUFA on immune markers in adolescent individuals at ultra-high risk for psychosis\u2014Results of the randomized controlled Vienna omega-3 study. Schizophrenia Res. 2017;188:110\u20137.","journal-title":"Schizophrenia Res"},{"key":"2217_CR47","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.bbi.2021.09.018","volume":"99","author":"SR Susai","year":"2021","unstructured":"Susai SR, Mongan D, Healy C, Cannon M, Nelson B, Markulev C, et al. The association of plasma inflammatory markers with omega-3 fatty acids and their mediating role in psychotic symptoms and functioning: An analysis of the NEURAPRO clinical trial. Brain, Behav, Immun. 2021;99:147\u201356.","journal-title":"Brain, Behav, Immun"},{"key":"2217_CR48","doi-asserted-by":"crossref","unstructured":"Amminger GP, Schafer MR, Schlogelhofer M, Klier CM, McGorry PD. Longer-term outcome in the prevention of psychotic disorders by the Vienna omega-3 study. Nat Commun. 2015;6:7934.","DOI":"10.1038\/ncomms8934"},{"key":"2217_CR49","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.134","volume":"5","author":"GP Amminger","year":"2015","unstructured":"Amminger GP, Mechelli A, Rice S, Kim SW, Klier CM, McNamara RK, et al. Predictors of treatment response in young people at ultra-high risk for psychosis who received long-chain omega-3 fatty acids. Transl Psychiatry. 2015;5:e495.","journal-title":"Transl Psychiatry"},{"key":"2217_CR50","doi-asserted-by":"crossref","unstructured":"World Medical Association Declaration of Helsinki: Ethical principles for medical research involving human subjects. JAMA. 2013;310:2191\u20134.","DOI":"10.1001\/jama.2013.281053"},{"key":"2217_CR51","doi-asserted-by":"publisher","first-page":"418","DOI":"10.1111\/eip.12260","volume":"11","author":"C Markulev","year":"2017","unstructured":"Markulev C, McGorry PD, Nelson B, Yuen HP, Schaefer M, Yung AR, et al. NEURAPRO-E study protocol: A multicentre randomized controlled trial of omega-3 fatty acids and cognitive-behavioural case management for patients at ultra high risk of schizophrenia and other psychotic disorders. Early Intervention Psychiatry. 2017;11:418\u201328.","journal-title":"Early Intervention Psychiatry"},{"key":"2217_CR52","doi-asserted-by":"publisher","first-page":"S132","DOI":"10.1093\/schbul\/sby016.325","volume":"44","author":"M Schl\u00f6gelhofer","year":"2018","unstructured":"Schl\u00f6gelhofer M, McGorry PD, Nelson B, Markulev C, Yuen HP, Sch\u00e5fer M, et al. The neurapro study: Adherence to study medication. Schizophrenia Bull. 2018;44:S132\u2013S133.","journal-title":"Schizophrenia Bull"},{"key":"2217_CR53","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1111\/eip.13025","volume":"15","author":"A McLaverty","year":"2021","unstructured":"McLaverty A, Allott KA, Berger M, Hester R, McGorry PD, Nelson B, et al. Omega\u20103 fatty acids and neurocognitive ability in young people at ultra\u2010high risk for psychosis. Early Intervention Psychiatry. 2021;15:874\u201381.","journal-title":"Early Intervention Psychiatry"},{"key":"2217_CR54","doi-asserted-by":"publisher","first-page":"286","DOI":"10.1016\/j.addr.2007.08.029","volume":"60","author":"F Pierig\u00e8","year":"2008","unstructured":"Pierig\u00e8 F, Serafini S, Rossi L, Magnani M. Cell-based drug delivery. Adv Drug Deliv Rev. 2008;60:286\u201395.","journal-title":"Adv Drug Deliv Rev"},{"key":"2217_CR55","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1007\/s11745-004-1317-0","volume":"39","author":"AJ Owen","year":"2004","unstructured":"Owen AJ, Peter\u2010Przyborowska BA, Hoy AJ, McLennan PL. Dietary fish oil dose\u2010and time\u2010response effects on cardiac phospholipid fatty acid composition. Lipids. 2004;39:955.","journal-title":"Lipids"},{"key":"2217_CR56","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1080\/j.1440-1614.2005.01714.x","volume":"39","author":"AR Yung","year":"2005","unstructured":"Yung AR, Yuen HP, McGorry PD, Phillips LJ, Kelly D, Dell\u2019Olio M, et al. Mapping the onset of psychosis: The Comprehensive Assessment of At-Risk Mental States. Aust NZ J Psychiatry. 2005;39:964\u201371.","journal-title":"Aust NZ J Psychiatry"},{"key":"2217_CR57","doi-asserted-by":"crossref","first-page":"e2233","DOI":"10.1136\/bmj.e360","volume":"344","author":"AP Morrison","year":"2012","unstructured":"Morrison AP, French P, Stewart SL, Birchwood M, Fowler D, Gumley AI, et al. Early detection and intervention evaluation for people at risk of psychosis: Multisite randomised controlled trial. BMJ (Clin Res ed). 2012;344:e2233.","journal-title":"BMJ (Clin Res ed)"},{"key":"2217_CR58","doi-asserted-by":"publisher","first-page":"788","DOI":"10.1016\/S2215-0366(20)30248-0","volume":"7","author":"AP Morrison","year":"2020","unstructured":"Morrison AP, Pyle M, Maughan D, Johns L, Freeman D, Broome MR, et al. Antipsychotic medication versus psychological intervention versus a combination of both in adolescents with first-episode psychosis (MAPS): A multicentre, three-arm, randomised controlled pilot and feasibility study. Lancet Psychiatry. 2020;7:788\u2013800.","journal-title":"Lancet Psychiatry"},{"key":"2217_CR59","doi-asserted-by":"publisher","first-page":"283","DOI":"10.1016\/j.schres.2003.09.011","volume":"68","author":"RS Keefe","year":"2004","unstructured":"Keefe RS, Goldberg TE, Harvey PD, Gold JM, Poe MP, Coughenour L. The brief assessment of cognition in schizophrenia: Reliability, sensitivity, and comparison with a standard neurocognitive battery. Schizophrenia Res. 2004;68:283\u201397.","journal-title":"Schizophrenia Res"},{"key":"2217_CR60","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1600-0447.2000.tb10933.x","volume":"101","author":"PL Morosini","year":"2000","unstructured":"Morosini PL, Magliano L, Brambilla L, Ugolini S, Pioli R. Development, reliability and acceptability of a new version of the DSM-IV Social and Occupational Functioning Assessment Scale (SOFAS) to assess routine social functioning. Acta Psychiatr Scandinavica. 2000;101:323\u20139.","journal-title":"Acta Psychiatr Scandinavica"},{"key":"2217_CR61","first-page":"D498","volume":"48","author":"B Jassal","year":"2020","unstructured":"Jassal B, Matthews L, Viteri G, Gong C, Lorente P, Fabregat A, et al. The reactome pathway knowledgebase. Nucleic Acids Res. 2020;48:D498\u2013D503.","journal-title":"Nucleic Acids Res"},{"key":"2217_CR62","unstructured":"Hayes AF. Introduction to mediation, moderation, and conditional process analysis second edition. A regression-based approach. Guilford Press, New York, 2017."},{"key":"2217_CR63","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1016\/j.biopsych.2019.08.030","volume":"87","author":"GP Amminger","year":"2020","unstructured":"Amminger GP, Nelson B, Markulev C, Yuen HP, Sch\u00e4fer MR, Berger M, et al. The NEURAPRO biomarker analysis: Long-chain omega-3 fatty acids improve 6-month and 12-month outcomes in youths at ultra-high risk for psychosis. Biol Psychiatry. 2020;87:243\u201352.","journal-title":"Biol Psychiatry"},{"key":"2217_CR64","doi-asserted-by":"publisher","first-page":"1062","DOI":"10.1016\/S2215-0366(21)00286-8","volume":"8","author":"HJ Jones","year":"2021","unstructured":"Jones HJ, Borges MC, Carnegie R, Mongan D, Rogers PJ, Lewis SJ, et al. Associations between plasma fatty acid concentrations and schizophrenia: a two-sample Mendelian randomisation study. Lancet Psychiatry. 2021;8:1062\u201370.","journal-title":"Lancet Psychiatry"},{"key":"2217_CR65","doi-asserted-by":"crossref","unstructured":"Coltell O, Sorl\u00ed JV, Asensio EM, Barrag\u00e1n R, Gonz\u00e1lez JI, Gim\u00e9nez-Alba IM et al. Genome-wide association study for serum omega-3 and omega-6 polyunsaturated fatty acids: Exploratory analysis of the sex-specific effects and dietary modulation in Mediterranean subjects with metabolic syndrome. Nutrients. 2020;12:310.","DOI":"10.3390\/nu12020310"},{"key":"2217_CR66","doi-asserted-by":"publisher","DOI":"10.1038\/s41398-018-0181-z","volume":"8","author":"KM Prasad","year":"2018","unstructured":"Prasad KM, Chowdari KV, D\u2019Aiuto LA, Iyengar S, Stanley JA, Nimgaonkar VL. Neuropil contraction in relation to Complement C4 gene copy numbers in independent cohorts of adolescent-onset and young adult-onset schizophrenia patients-a pilot study. Transl Psychiatry. 2018;8:134.","journal-title":"Transl Psychiatry"},{"key":"2217_CR67","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1038\/nature16549","volume":"530","author":"A Sekar","year":"2016","unstructured":"Sekar A, Bialas AR, de Rivera H, Davis A, Hammond TR, Kamitaki N, et al. Schizophrenia risk from complex variation of complement component 4. Nature. 2016;530:177\u201383.","journal-title":"Nature"},{"key":"2217_CR68","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1038\/nrn.2016.20","volume":"17","author":"K Whalley","year":"2016","unstructured":"Whalley K. Psychiatric disorders: Linking genetic risk to pruning. Nat Rev Neurosci. 2016;17:199\u2013199.","journal-title":"Nat Rev Neurosci"},{"key":"2217_CR69","doi-asserted-by":"publisher","first-page":"214","DOI":"10.1038\/s41593-020-00763-8","volume":"24","author":"M Yilmaz","year":"2021","unstructured":"Yilmaz M, Yalcin E, Presumey J, Aw E, Ma M, Whelan CW, et al. Overexpression of schizophrenia susceptibility factor human complement C4A promotes excessive synaptic loss and behavioral changes in mice. Nat Neurosci. 2021;24:214\u201324.","journal-title":"Nat Neurosci"},{"key":"2217_CR70","doi-asserted-by":"publisher","first-page":"2002","DOI":"10.3389\/fimmu.2020.02002","volume":"11","author":"TD Purves-Tyson","year":"2020","unstructured":"Purves-Tyson TD, Robinson K, Brown AM, Boerrigter D, Cai HQ, Weissleder C, et al. Increased macrophages and C1qA, C3, C4 transcripts in the midbrain of people with schizophrenia. Front Immunol. 2020;11:2002.","journal-title":"Front Immunol"},{"key":"2217_CR71","doi-asserted-by":"publisher","first-page":"1135","DOI":"10.1161\/ATVBAHA.119.313286","volume":"40","author":"RP Mason","year":"2020","unstructured":"Mason RP, Libby P, Bhatt DL. Emerging mechanisms of cardiovascular protection for the omega-3 fatty acid eicosapentaenoic acid. Arteriosclerosis, Thrombosis, Vasc Biol. 2020;40:1135\u201347.","journal-title":"Arteriosclerosis, Thrombosis, Vasc Biol"},{"key":"2217_CR72","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1038\/s41581-021-00454-y","volume":"17","author":"E Brennan","year":"2021","unstructured":"Brennan E, Kantharidis P, Cooper ME, Godson C. Pro-resolving lipid mediators: Regulators of inflammation, metabolism, and kidney function. Nat Rev Nephrol. 2021;17:725\u201339.","journal-title":"Nat Rev Nephrol"},{"key":"2217_CR73","doi-asserted-by":"crossref","unstructured":"Amatruda M, Ippolito G, Vizzuso S, Vizzari G, Banderali G, Verduci E. Epigenetic effects of n-3 LCPUFAs: A role in pediatric metabolic syndrome. Int. J. Mol. Sci. 2019;20:2118.","DOI":"10.3390\/ijms20092118"},{"key":"2217_CR74","first-page":"109","volume":"9","author":"N Tajuddin","year":"2016","unstructured":"Tajuddin N, Shaikh A, Hassan A. Prescription omega-3 fatty acid products: Considerations for patients with diabetes mellitus. Diabetes Metab Syndr Obes. 2016;9:109\u201318.","journal-title":"Diabetes Metab Syndr Obes"},{"key":"2217_CR75","doi-asserted-by":"publisher","first-page":"1952","DOI":"10.1016\/j.clnu.2018.07.037","volume":"38","author":"A Manousopoulou","year":"2019","unstructured":"Manousopoulou A, Scorletti E, Smith DE, Teng J, Fotopoulos M, Roumeliotis TI, et al. Marine omega-3 fatty acid supplementation in non-alcoholic fatty liver disease: Plasma proteomics in the randomized WELCOME* trial. Clin Nutr. 2019;38:1952\u20135.","journal-title":"Clin Nutr"},{"key":"2217_CR76","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1016\/j.phrs.2007.01.013","volume":"55","author":"WS Harris","year":"2007","unstructured":"Harris WS. Omega-3 fatty acids and cardiovascular disease: A case for omega-3 index as a new risk factor. Pharmacol Res. 2007;55:217\u201323.","journal-title":"Pharmacol Res"},{"key":"2217_CR77","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1038\/ejcn.2011.39","volume":"65","author":"Z Makhoul","year":"2011","unstructured":"Makhoul Z, Kristal AR, Gulati R, Luick B, Bersamin A, O\u2019Brien D, et al. Associations of obesity with triglycerides and C-reactive protein are attenuated in adults with high red blood cell eicosapentaenoic and docosahexaenoic acids. Eur J Clin Nutr. 2011;65:808\u201317.","journal-title":"Eur J Clin Nutr"},{"key":"2217_CR78","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1093\/schbul\/sbx075","volume":"44","author":"JA English","year":"2018","unstructured":"English JA, Lopez LM, O\u2019Gorman A, F\u00f6cking M, Hryniewiecka M, Scaife C, et al. Blood-based protein changes in childhood are associated with increased risk for later psychotic disorder: Evidence from a nested case-control study of the ALSPAC longitudinal birth cohort. Schizophr Bull. 2018;44:297\u2013306.","journal-title":"Schizophr Bull"},{"key":"2217_CR79","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1016\/j.biopsych.2019.01.018","volume":"86","author":"F Madrid-Gambin","year":"2019","unstructured":"Madrid-Gambin F, F\u00f6cking M, Sabherwal S, Heurich M, English JA, O\u2019Gorman A, et al. Integrated lipidomics and proteomics point to early blood-based changes in childhood preceding later development of psychotic experiences: Evidence from the Avon longitudinal study of parents and children. Biol Psychiatry. 2019;86:25\u201334.","journal-title":"Biol Psychiatry"},{"key":"2217_CR80","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1001\/jamapsychiatry.2020.2459","volume":"78","author":"D Mongan","year":"2021","unstructured":"Mongan D, F\u00f6cking M, Healy C, Susai SR, Heurich M, Wynne K, et al. Development of proteomic prediction models for transition to psychotic disorder in the clinical high-risk state and psychotic experiences in adolescence. JAMA Psychiatry. 2021;78:77\u201390.","journal-title":"JAMA Psychiatry"},{"key":"2217_CR81","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1038\/s41380-018-0306-z","volume":"26","author":"M F\u00f6cking","year":"2021","unstructured":"F\u00f6cking M, Sabherwal S, Cates HM, Scaife C, Dicker P, Hryniewiecka M, et al. Complement pathway changes at age 12 are associated with psychotic experiences at age 18 in a longitudinal population-based study: Evidence for a role of stress. Mol Psychiatry. 2021;26:524\u201333.","journal-title":"Mol Psychiatry"},{"key":"2217_CR82","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1016\/j.schres.2019.05.002","volume":"209","author":"S Sabherwal","year":"2019","unstructured":"Sabherwal S, F\u00f6cking M, English JA, Fitzsimons S, Hryniewiecka M, Wynne K, et al. ApoE elevation is associated with the persistence of psychotic experiences from age 12 to age 18: Evidence from the ALSPAC birth cohort. Schizophr Res. 2019;209:141\u20137.","journal-title":"Schizophr Res"},{"key":"2217_CR83","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1016\/j.schres.2020.05.036","volume":"222","author":"D Mongan","year":"2020","unstructured":"Mongan D, Sabherwal S, Susai SR, F\u00f6cking M, Cannon M, Cotter DR. Peripheral complement proteins in schizophrenia: A systematic review and meta-analysis of serological studies. Schizophr Res. 2020;222:58\u201372.","journal-title":"Schizophr Res"},{"key":"2217_CR84","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.schres.2015.08.031","volume":"169","author":"TB Gonz\u00e1lez-Castro","year":"2015","unstructured":"Gonz\u00e1lez-Castro TB, Tovilla-Z\u00e1rate CA, Hern\u00e1ndez-D\u00edaz Y, Fres\u00e1n A, Ju\u00e1rez-Rojop IE, Ble-Castillo JL, et al. No association between ApoE and schizophrenia: Evidence of systematic review and updated meta-analysis. Schizophrenia Res. 2015;169:355\u201368.","journal-title":"Schizophrenia Res"},{"key":"2217_CR85","doi-asserted-by":"publisher","first-page":"1298","DOI":"10.3389\/fimmu.2018.01298","volume":"9","author":"S Wang","year":"2018","unstructured":"Wang S, Song R, Wang Z, Jing Z, Wang S, Ma J. S100A8\/A9 in inflammation. Front Immunol. 2018;9:1298.","journal-title":"Front Immunol"},{"key":"2217_CR86","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1016\/j.immuni.2013.11.011","volume":"39","author":"B Schonthaler Helia","year":"2013","unstructured":"Schonthaler Helia B, Guinea-Viniegra J, Wculek Stefanie K, Ruppen I, Xim\u00e9nez-Emb\u00fan P, Gu\u00edo-Carri\u00f3n A, et al. S100A8-S100A9 protein complex mediates psoriasis by regulating the expression of complement factor C3. Immunity. 2013;39:1171\u201381.","journal-title":"Immunity"},{"key":"2217_CR87","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1086\/651257","volume":"37","author":"X Zhao","year":"2010","unstructured":"Zhao X, Lynch J, Chen Q. Reconsidering Baron and Kenny: Myths and truths about Mediation analysis. J Consum Res. 2010;37:197\u2013206.","journal-title":"J Consum Res"},{"key":"2217_CR88","doi-asserted-by":"publisher","first-page":"373","DOI":"10.1016\/j.tins.2018.03.009","volume":"41","author":"LG Coulthard","year":"2018","unstructured":"Coulthard LG, Hawksworth OA, Woodruff TM. Complement: The emerging architect of the developing brain. Trends Neurosci. 2018;41:373\u201384.","journal-title":"Trends Neurosci"},{"key":"2217_CR89","doi-asserted-by":"crossref","unstructured":"Heurich M, F\u00f6cking M, Mongan D, Cagney G, Cotter DR. Dysregulation of complement and coagulation pathways: Emerging mechanisms in the development of psychosis. Mol Psychiatry. 2021;27:1\u201314.","DOI":"10.1038\/s41380-021-01197-9"},{"key":"2217_CR90","doi-asserted-by":"publisher","first-page":"5395","DOI":"10.1523\/JNEUROSCI.0525-17.2017","volume":"37","author":"LG Coulthard","year":"2017","unstructured":"Coulthard LG, Hawksworth OA, Li R, Balachandran A, Lee JD, Sepehrband F, et al. Complement C5aR1 signaling promotes polarization and proliferation of embryonic neural progenitor cells through PKCzeta. J Neurosci: Off J Soc Neurosci. 2017;37:5395\u2013407.","journal-title":"J Neurosci: Off J Soc Neurosci"},{"key":"2217_CR91","doi-asserted-by":"publisher","first-page":"3549","DOI":"10.1021\/acschemneuro.0c00365","volume":"11","author":"Y Tian","year":"2020","unstructured":"Tian Y, Cao R, Che B, Sun D, Tang Y, Jiang L, et al. Proinflammatory S100A9 regulates differentiation and aggregation of neural stem cells. ACS Chem Neurosci. 2020;11:3549\u201356.","journal-title":"ACS Chem Neurosci"},{"key":"2217_CR92","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1016\/j.neulet.2019.02.012","volume":"699","author":"C Wang","year":"2019","unstructured":"Wang C, Iashchishyn IA, Kara J, Foder\u00e0 V, Vetri V, Sancataldo G, et al. Proinflammatory and amyloidogenic S100A9 induced by traumatic brain injury in mouse model. Neurosci Lett. 2019;699:199\u2013205.","journal-title":"Neurosci Lett"},{"key":"2217_CR93","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/S0920-9964(12)70039-7","volume":"136","author":"D Schafer","year":"2012","unstructured":"Schafer D, Lehrman EK, Kautzman AG, Koyama R, Mardinly AR, Greenberg ME, et al. Microglia and the complement cascade: Shaping neural circuits in the developing brain. Schizophrenia Res. 2012;136:S11\u2013S12.","journal-title":"Schizophrenia Res"},{"key":"2217_CR94","doi-asserted-by":"publisher","first-page":"191","DOI":"10.1111\/j.1460-9568.2010.07346.x","volume":"32","author":"M Yuzaki","year":"2010","unstructured":"Yuzaki M. Synapse formation and maintenance by C1q family proteins: A new class of secreted synapse organizers. Eur J Neurosci. 2010;32:191\u20137.","journal-title":"Eur J Neurosci"},{"issue":"Suppl 2","key":"2217_CR95","doi-asserted-by":"publisher","first-page":"S64","DOI":"10.1017\/S000711451200147X","volume":"107","author":"L Serra-Majem","year":"2012","unstructured":"Serra-Majem L, Nissensohn M, \u00d8verby NC, Fekete K. Dietary methods and biomarkers of omega 3 fatty acids: A systematic review. Br J Nutr. 2012;107 Suppl 2:S64\u201376.","journal-title":"Br J Nutr"},{"key":"2217_CR96","first-page":"29","volume":"20","author":"A Sidhu","year":"2021","unstructured":"Sidhu A, Bhalla P, Zafar S. Mediating effect and review of its statistical measures. Empir Econ Lett. 2021;20:29\u201340.","journal-title":"Empir Econ Lett"},{"key":"2217_CR97","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1111\/eip.13182","volume":"16","author":"GP Amminger","year":"2022","unstructured":"Amminger GP, Lin A, Kerr M, Weller A, Spark J, Pugh C, et al. Cannabidiol for at risk for psychosis youth: A randomized controlled trial. Early Inter Psychiatry. 2022;16:419\u201332.","journal-title":"Early Inter Psychiatry"}],"container-title":["Translational Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02217-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02217-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02217-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,10,30]],"date-time":"2022-10-30T09:05:18Z","timestamp":1667120718000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41398-022-02217-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,10,28]]},"references-count":97,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2022,12]]}},"alternative-id":["2217"],"URL":"https:\/\/doi.org\/10.1038\/s41398-022-02217-0","relation":{},"ISSN":["2158-3188"],"issn-type":[{"value":"2158-3188","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,10,28]]},"assertion":[{"value":"11 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 September 2022","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 October 2022","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"28 October 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"454"}}